United States Biotechnology & Medical Research

Aurinia Pharmaceuticals Inc (AUP)

Track

Track

Aurinia Pharmaceuticals recently observed insider trading activity involving Chief Legal Officer Stephen P. Robertson, who executed sales totaling approximately 1.27 million dollars. These divestments occurred following previous periods of significant accumulation by executive leadership. Market participants monitor such shifts closely, especially given the historical context of the company's last reported results.
Ticker: AUP Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Aurinia Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.6
Robertson Stephen P. Chief Legal Officer Officer
Transaction date
Sale
Price
335.14
Quantity 35,685 -32.8%
Value US$2,943,655
0.6
Robertson Stephen P. Chief Legal Officer Officer
Transaction date
Sale
Price
448.76
Quantity 59,493 -25.7%
Value US$2,464,412
0.6
Stephen P. Robertson Officer Officer
Transaction date
Proposed sale
Price
275.06
Quantity 25,918
Value US$3,713,158
GREGORY KEENAN Former Affiliate
Transaction date
Proposed sale
Price
16.52
Quantity 9,593
Value US$158,490
GREGORY KEENAN Former Affiliate
Transaction date
Proposed sale
Price
16.52
Quantity 9,593
Value US$158,490
GREGORY KEENAN Former Affiliate
Transaction date
Proposed sale
Price
16.34
Quantity 25,000
Value US$408,435
Tang, Kevin Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
15.28
Quantity 103,002 +60.0%
Value US$1,573,871
Tang, Kevin Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
15.28
Quantity 103,003 +46.4%
Value US$1,573,886
3.3
TANG KEVIN Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
15.28
Quantity 206,005 +1.6%
Value US$3,147,756
GREGORY KEENAN Officer Officer
Transaction date
Proposed sale
Price
2,164.00
Quantity 25,000
Value US$54,100,000
Tang, Kevin Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
15.34
Quantity 49 +0.0%
Value US$752
Tang, Kevin Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
15.28
Quantity 171,760
Value US$2,624,493
Tang, Kevin Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
15.34
Quantity 50 +0.0%
Value US$767
Tang, Kevin Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
15.28
Quantity 171,761 +343.5%
Value US$2,624,508
3.3
TANG KEVIN Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
15.34
Quantity 99 +0.0%
Value US$1,519
3.3
TANG KEVIN Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
15.28
Quantity 343,521 +2.7%
Value US$5,249,001
Tang, Kevin Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
15.31
Quantity 262,682 +3.8%
Value US$4,021,661
Tang, Kevin Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
15.35
Quantity 2,299 +0.0%
Value US$35,290
3.3
TANG KEVIN Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
15.31
Quantity 262,682 +2.1%
Value US$4,021,661
3.3
TANG KEVIN Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
15.35
Quantity 2,299 +0.0%
Value US$35,290
2.5
PETER GREENLEAF Former Affiliate
Transaction date
Proposed sale
Price
15.84
Quantity 3,136,201
Value US$49,677,424
MATTHEW MAXWELL DONLEY Former Affiliate
Transaction date
Proposed sale
Price
15.84
Quantity 717,688
Value US$11,368,178
JOSEPH MILLER Former Affiliate
Transaction date
Proposed sale
Price
15.84
Quantity 500,503
Value US$7,927,968
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
14.22
Quantity 184,208 +1.5%
Value US$2,619,438
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
14.21
Quantity 115,792 +1.0%
Value US$1,645,404
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
14.33
Quantity 83,561 +0.7%
Value US$1,197,429
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
14.38
Quantity 1,600 +0.0%
Value US$23,008
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
14.12
Quantity 214,839 +1.8%
Value US$3,033,527
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
13.90
Quantity 300,000 +2.6%
Value US$4,170,000
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
11.68
Quantity 200,000 +1.8%
Value US$2,336,000
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
11.34
Quantity 100,000 +0.9%
Value US$1,134,000
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
10.12
Quantity 1,000,000 +10.0%
Value US$10,120,000
Keenan Greg Chief Medical Officer Officer
Transaction date
Sale
Price
10.50
Quantity 20,000 -13.0%
Value US$210,000
Keenan Greg Chief Medical Officer Officer
Transaction date
Sale
Price
8.23
Quantity 8,305 -5.1%
Value US$68,350
2.5
Greenleaf Peter Chief Executive Officer Executive Director
Transaction date
Sale
Price
7.92
Quantity 164,947 -8.4%
Value US$1,306,380
Miller Joseph M Chief Financial Officer Officer
Transaction date
Sale
Price
7.92
Quantity 56,154 -8.9%
Value US$444,740
0.6
Robertson Stephen P. EVP, General Counsel Officer
Transaction date
Sale
Price
7.92
Quantity 57,607 -10.2%
Value US$456,247
Donley Matthew Maxwell Chief Operating Officer Officer
Transaction date
Sale
Price
7.92
Quantity 58,991 -8.0%
Value US$467,209
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
8.09
Quantity 100,000 +1.0%
Value US$809,000
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
7.92
Quantity 500,000 +5.3%
Value US$3,960,000
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
8.00
Quantity 148,038 +1.6%
Value US$1,184,304
Keenan Greg Chief Medical Officer Officer
Transaction date
Sale
Price
8.00
Quantity 12,239 -7.0%
Value US$97,912
2.5
Greenleaf Peter Chief Executive Officer Executive Director
Transaction date
Sale
Price
8.00
Quantity 195,593 -9.1%
Value US$1,564,744
Miller Joseph M Chief Financial Officer Officer
Transaction date
Sale
Price
8.00
Quantity 61,859 -8.9%
Value US$494,872
0.6
Robertson Stephen P. EVP, General Counsel Officer
Transaction date
Sale
Price
8.00
Quantity 64,872 -10.3%
Value US$518,976
Donley Matthew Maxwell Chief Operating Officer Officer
Transaction date
Sale
Price
8.00
Quantity 65,902 -8.2%
Value US$527,216
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
8.02
Quantity 351,962 +3.9%
Value US$2,822,735
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
7.97
Quantity 100,720 +1.1%
Value US$802,738
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
7.85
Quantity 399,280 +4.7%
Value US$3,134,348
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
9.09
Quantity 500,000 +6.3%
Value US$4,545,000
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
9.01
Quantity 400,000 +5.3%
Value US$3,604,000
3.3
TANG KEVIN Non-Executive Director
Transaction date
Purchase
Price
8.91
Quantity 300,000 +4.1%
Value US$2,673,000
3.3
Bailey Jeffrey Allen Non-Executive Director
Transaction date
Sale
Price
8.43
Quantity 4,557 -25.4%
Value US$38,416
Smith Karen L. Non-Executive Director
Transaction date
Sale
Price
8.43
Quantity 5,241 -29.3%
Value US$44,182
Habig Scott Michael Chief Commercial Officer Officer
Transaction date
Sale
Price
5.31
Quantity 18,249 -3.8%
Value US$96,902
2.4
Balakrishnan Brinda Non-Executive Director
Transaction date
Sale
Price
5.74
Quantity 520 -2.9%
Value US$2,985
MacKay-Dunn R. Hector Non-Executive Director
Transaction date
Sale
Price
5.74
Quantity 5,630 -23.2%
Value US$32,316
MacKay-Dunn R. Hector Non-Executive Director
Transaction date
Sale
Price
5.74
Quantity 5,630 -23.2%
Value US$32,316
Billen Daniel Non-Executive Director
Transaction date
Sale
Price
5.74
Quantity 5,252 -15.7%
Value US$30,146
Billen Daniel Non-Executive Director
Transaction date
Sale
Price
5.74
Quantity 5,252 -15.7%
Value US$30,146
0.6
Leversage Jill Non-Executive Director
Transaction date
Sale
Price
5.74
Quantity 5,610 -30.3%
Value US$32,201
0.6
Leversage Jill Non-Executive Director
Transaction date
Sale
Price
5.74
Quantity 5,610 -30.3%
Value US$32,201
Jayne David R.W. Non-Executive Director
Transaction date
Sale
Price
5.74
Quantity 4,946 -10.0%
Value US$28,390
Jayne David R.W. Non-Executive Director
Transaction date
Sale
Price
5.74
Quantity 4,946 -10.0%
Value US$28,390
3.6
MacKay-Dunn, R. Hector Director of Issuer Non-Executive Director
Transaction date
Sale
Price
5.74
Quantity 5,630 -42.6%
Value US$32,316
Habig Scott Michael Chief Commercial Officer Officer
Transaction date
Sale
Price
5.60
Quantity 17,777 -3.6%
Value US$99,551
2.5
Greenleaf Peter Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.60
Quantity 126,981 -7.7%
Value US$711,094
Miller Joseph M Chief Financial Officer Officer
Transaction date
Sale
Price
5.60
Quantity 34,811 -6.6%
Value US$194,942
0.6
Robertson Stephen P. EVP, General Counsel Officer
Transaction date
Sale
Price
5.60
Quantity 57,745 -11.5%
Value US$323,372
Donley Matthew Maxwell EVP, Ops & Strategy Officer
Transaction date
Sale
Price
5.51
Quantity 40,665 -6.5%
Value US$224,064
Knappertz Volker EVP, Research and Development Officer
Transaction date
Sale
Price
6.10
Quantity 4,930 -1.5%
Value US$30,073
Knappertz, Volker Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
6.10
Quantity 4,930 -16.0%
Value US$30,073
Donley, Matthew Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
4,930.00
Quantity 4,930 +7.9%
Value CA$24,304,900
Habig Scott Michael Chief Commercial Officer Officer
Transaction date
Sale
Price
5.48
Quantity 15,867 -3.1%
Value US$86,951
Knappertz Volker EVP, Research and Development Officer
Transaction date
Sale
Price
5.48
Quantity 25,146 -7.2%
Value US$137,800
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-11 2026-09-10 S Sale
0.6
Robertson Stephen P.

Chief Legal Officer

Officer
35,685 -32.8%
335.14
US$2,943,655 		35,685 -32.8% 335.14 US$2,943,655
2026-08-25 2026-08-21 S Sale
0.6
Robertson Stephen P.

Chief Legal Officer

Officer
59,493 -25.7%
448.76
US$2,464,412 		59,493 -25.7% 448.76 US$2,464,412
2026-08-21 2026-08-21 PrS Proposed sale
0.6
Stephen P. Robertson

Officer

Officer
25,918
275.06
US$3,713,158 		25,918 275.06 US$3,713,158
2026-06-05 2026-06-05 PrS Proposed sale
GREGORY KEENAN

Former Affiliate
9,593
16.52
US$158,490 		9,593 16.52 US$158,490
2026-06-05 2026-06-05 PrS Proposed sale
GREGORY KEENAN

Former Affiliate
9,593
16.52
US$158,490 		9,593 16.52 US$158,490
2026-06-04 2026-06-04 PrS Proposed sale
GREGORY KEENAN

Former Affiliate
25,000
16.34
US$408,435 		25,000 16.34 US$408,435
2026-06-03 2026-06-02 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
103,002 +60.0%
15.28
US$1,573,871 		103,002 +60.0% 15.28 US$1,573,871
2026-06-03 2026-06-02 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
103,003 +46.4%
15.28
US$1,573,886 		103,003 +46.4% 15.28 US$1,573,886
2026-06-02 2026-06-02 B Purchase
3.3
TANG KEVIN

Chief Executive Officer

Executive Director Large shareholder
206,005 +1.6%
15.28
US$3,147,756 		206,005 +1.6% 15.28 US$3,147,756
2026-06-02 2026-06-02 PrS Proposed sale
GREGORY KEENAN

Officer

Officer
25,000
2,164.00
US$54,100,000 		25,000 2,164.00 US$54,100,000
2026-06-03 2026-06-01 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
49 +0.0%
15.34
US$752 		49 +0.0% 15.34 US$752
2026-06-03 2026-06-01 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
171,760
15.28
US$2,624,493 		171,760 15.28 US$2,624,493
2026-06-03 2026-06-01 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
50 +0.0%
15.34
US$767 		50 +0.0% 15.34 US$767
2026-06-03 2026-06-01 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
171,761 +343.5%
15.28
US$2,624,508 		171,761 +343.5% 15.28 US$2,624,508
2026-06-02 2026-06-01 B Purchase
3.3
TANG KEVIN

Chief Executive Officer

Executive Director Large shareholder
99 +0.0%
15.34
US$1,519 		99 +0.0% 15.34 US$1,519
2026-06-02 2026-06-01 B Purchase
3.3
TANG KEVIN

Chief Executive Officer

Executive Director Large shareholder
343,521 +2.7%
15.28
US$5,249,001 		343,521 +2.7% 15.28 US$5,249,001
2026-06-03 2026-05-29 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
262,682 +3.8%
15.31
US$4,021,661 		262,682 +3.8% 15.31 US$4,021,661
2026-06-03 2026-05-29 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
2,299 +0.0%
15.35
US$35,290 		2,299 +0.0% 15.35 US$35,290
2026-06-02 2026-05-29 B Purchase
3.3
TANG KEVIN

Chief Executive Officer

Executive Director Large shareholder
262,682 +2.1%
15.31
US$4,021,661 		262,682 +2.1% 15.31 US$4,021,661
2026-06-02 2026-05-29 B Purchase
3.3
TANG KEVIN

Chief Executive Officer

Executive Director Large shareholder
2,299 +0.0%
15.35
US$35,290 		2,299 +0.0% 15.35 US$35,290
2026-05-11 2026-05-11 PrS Proposed sale
2.5
PETER GREENLEAF

Former Affiliate
3,136,201
15.84
US$49,677,424 		3,136,201 15.84 US$49,677,424
2026-05-11 2026-05-11 PrS Proposed sale
MATTHEW MAXWELL DONLEY

Former Affiliate
717,688
15.84
US$11,368,178 		717,688 15.84 US$11,368,178
2026-05-11 2026-05-11 PrS Proposed sale
JOSEPH MILLER

Former Affiliate
500,503
15.84
US$7,927,968 		500,503 15.84 US$7,927,968
2026-03-03 2026-03-03 B Purchase
3.3
TANG KEVIN
Non-Executive Director
184,208 +1.5%
14.22
US$2,619,438 		184,208 +1.5% 14.22 US$2,619,438
2026-03-03 2026-03-02 B Purchase
3.3
TANG KEVIN
Non-Executive Director
115,792 +1.0%
14.21
US$1,645,404 		115,792 +1.0% 14.21 US$1,645,404
2026-03-03 2026-03-02 B Purchase
3.3
TANG KEVIN
Non-Executive Director
83,561 +0.7%
14.33
US$1,197,429 		83,561 +0.7% 14.33 US$1,197,429
2026-03-03 2026-02-27 B Purchase
3.3
TANG KEVIN
Non-Executive Director
1,600 +0.0%
14.38
US$23,008 		1,600 +0.0% 14.38 US$23,008
2026-03-03 2026-02-27 B Purchase
3.3
TANG KEVIN
Non-Executive Director
214,839 +1.8%
14.12
US$3,033,527 		214,839 +1.8% 14.12 US$3,033,527
2026-03-03 2026-02-27 B Purchase
3.3
TANG KEVIN
Non-Executive Director
300,000 +2.6%
13.90
US$4,170,000 		300,000 +2.6% 13.90 US$4,170,000
2025-08-05 2025-08-05 B Purchase
3.3
TANG KEVIN
Non-Executive Director
200,000 +1.8%
11.68
US$2,336,000 		200,000 +1.8% 11.68 US$2,336,000
2025-08-05 2025-08-04 B Purchase
3.3
TANG KEVIN
Non-Executive Director
100,000 +0.9%
11.34
US$1,134,000 		100,000 +0.9% 11.34 US$1,134,000
2025-08-05 2025-08-01 B Purchase
3.3
TANG KEVIN
Non-Executive Director
1,000,000 +10.0%
10.12
US$10,120,000 		1,000,000 +10.0% 10.12 US$10,120,000
2025-08-05 2025-08-01 S Sale
Keenan Greg

Chief Medical Officer

Officer
20,000 -13.0%
10.50
US$210,000 		20,000 -13.0% 10.50 US$210,000
2025-03-07 2025-03-07 S Sale
Keenan Greg

Chief Medical Officer

Officer
8,305 -5.1%
8.23
US$68,350 		8,305 -5.1% 8.23 US$68,350
2025-03-04 2025-03-04 S Sale
2.5
Greenleaf Peter

Chief Executive Officer

Executive Director
164,947 -8.4%
7.92
US$1,306,380 		164,947 -8.4% 7.92 US$1,306,380
2025-03-04 2025-03-04 S Sale
Miller Joseph M

Chief Financial Officer

Officer
56,154 -8.9%
7.92
US$444,740 		56,154 -8.9% 7.92 US$444,740
2025-03-04 2025-03-04 S Sale
0.6
Robertson Stephen P.

EVP, General Counsel

Officer
57,607 -10.2%
7.92
US$456,247 		57,607 -10.2% 7.92 US$456,247
2025-03-04 2025-03-04 S Sale
Donley Matthew Maxwell

Chief Operating Officer

Officer
58,991 -8.0%
7.92
US$467,209 		58,991 -8.0% 7.92 US$467,209
2025-03-04 2025-03-04 B Purchase
3.3
TANG KEVIN
Non-Executive Director
100,000 +1.0%
8.09
US$809,000 		100,000 +1.0% 8.09 US$809,000
2025-03-04 2025-03-04 B Purchase
3.3
TANG KEVIN
Non-Executive Director
500,000 +5.3%
7.92
US$3,960,000 		500,000 +5.3% 7.92 US$3,960,000
2025-03-04 2025-03-04 B Purchase
3.3
TANG KEVIN
Non-Executive Director
148,038 +1.6%
8.00
US$1,184,304 		148,038 +1.6% 8.00 US$1,184,304
2025-03-04 2025-03-03 S Sale
Keenan Greg

Chief Medical Officer

Officer
12,239 -7.0%
8.00
US$97,912 		12,239 -7.0% 8.00 US$97,912
2025-03-04 2025-03-03 S Sale
2.5
Greenleaf Peter

Chief Executive Officer

Executive Director
195,593 -9.1%
8.00
US$1,564,744 		195,593 -9.1% 8.00 US$1,564,744
2025-03-04 2025-03-03 S Sale
Miller Joseph M

Chief Financial Officer

Officer
61,859 -8.9%
8.00
US$494,872 		61,859 -8.9% 8.00 US$494,872
2025-03-04 2025-03-03 S Sale
0.6
Robertson Stephen P.

EVP, General Counsel

Officer
64,872 -10.3%
8.00
US$518,976 		64,872 -10.3% 8.00 US$518,976
2025-03-04 2025-03-03 S Sale
Donley Matthew Maxwell

Chief Operating Officer

Officer
65,902 -8.2%
8.00
US$527,216 		65,902 -8.2% 8.00 US$527,216
2025-03-04 2025-03-03 B Purchase
3.3
TANG KEVIN
Non-Executive Director
351,962 +3.9%
8.02
US$2,822,735 		351,962 +3.9% 8.02 US$2,822,735
2025-03-04 2025-03-03 B Purchase
3.3
TANG KEVIN
Non-Executive Director
100,720 +1.1%
7.97
US$802,738 		100,720 +1.1% 7.97 US$802,738
2025-03-04 2025-02-28 B Purchase
3.3
TANG KEVIN
Non-Executive Director
399,280 +4.7%
7.85
US$3,134,348 		399,280 +4.7% 7.85 US$3,134,348
2024-12-09 2024-12-09 B Purchase
3.3
TANG KEVIN
Non-Executive Director
500,000 +6.3%
9.09
US$4,545,000 		500,000 +6.3% 9.09 US$4,545,000
2024-12-09 2024-12-06 B Purchase
3.3
TANG KEVIN
Non-Executive Director
400,000 +5.3%
9.01
US$3,604,000 		400,000 +5.3% 9.01 US$3,604,000
2024-12-09 2024-12-05 B Purchase
3.3
TANG KEVIN
Non-Executive Director
300,000 +4.1%
8.91
US$2,673,000 		300,000 +4.1% 8.91 US$2,673,000
2024-11-12 2024-11-11 S Sale
3.3
Bailey Jeffrey Allen
Non-Executive Director
4,557 -25.4%
8.43
US$38,416 		4,557 -25.4% 8.43 US$38,416
2024-11-12 2024-11-11 S Sale
Smith Karen L.
Non-Executive Director
5,241 -29.3%
8.43
US$44,182 		5,241 -29.3% 8.43 US$44,182
2024-08-08 2024-08-06 S Sale
Habig Scott Michael

Chief Commercial Officer

Officer
18,249 -3.8%
5.31
US$96,902 		18,249 -3.8% 5.31 US$96,902
2024-05-22 2024-05-21 S Sale
2.4
Balakrishnan Brinda
Non-Executive Director
520 -2.9%
5.74
US$2,985 		520 -2.9% 5.74 US$2,985
2024-05-22 2024-05-21 S Sale
MacKay-Dunn R. Hector
Non-Executive Director
5,630 -23.2%
5.74
US$32,316 		5,630 -23.2% 5.74 US$32,316
2024-05-22 2024-05-21 S Sale
MacKay-Dunn R. Hector
Non-Executive Director
5,630 -23.2%
5.74
US$32,316 		5,630 -23.2% 5.74 US$32,316
2024-05-22 2024-05-21 S Sale
Billen Daniel
Non-Executive Director
5,252 -15.7%
5.74
US$30,146 		5,252 -15.7% 5.74 US$30,146
2024-05-22 2024-05-21 S Sale
Billen Daniel
Non-Executive Director
5,252 -15.7%
5.74
US$30,146 		5,252 -15.7% 5.74 US$30,146
2024-05-22 2024-05-21 S Sale
0.6
Leversage Jill
Non-Executive Director
5,610 -30.3%
5.74
US$32,201 		5,610 -30.3% 5.74 US$32,201
2024-05-22 2024-05-21 S Sale
0.6
Leversage Jill
Non-Executive Director
5,610 -30.3%
5.74
US$32,201 		5,610 -30.3% 5.74 US$32,201
2024-05-22 2024-05-21 S Sale
Jayne David R.W.
Non-Executive Director
4,946 -10.0%
5.74
US$28,390 		4,946 -10.0% 5.74 US$28,390
2024-05-22 2024-05-21 S Sale
Jayne David R.W.
Non-Executive Director
4,946 -10.0%
5.74
US$28,390 		4,946 -10.0% 5.74 US$28,390
2024-05-22 2024-05-21 S Sale
3.6
MacKay-Dunn, R. Hector

Director of Issuer

Non-Executive Director
5,630 -42.6%
5.74
US$32,316 		5,630 -42.6% 5.74 US$32,316
2024-03-07 2024-03-06 S Sale
Habig Scott Michael

Chief Commercial Officer

Officer
17,777 -3.6%
5.60
US$99,551 		17,777 -3.6% 5.60 US$99,551
2024-03-07 2024-03-06 S Sale
2.5
Greenleaf Peter

Chief Executive Officer

Executive Director
126,981 -7.7%
5.60
US$711,094 		126,981 -7.7% 5.60 US$711,094
2024-03-07 2024-03-06 S Sale
Miller Joseph M

Chief Financial Officer

Officer
34,811 -6.6%
5.60
US$194,942 		34,811 -6.6% 5.60 US$194,942
2024-03-07 2024-03-06 S Sale
0.6
Robertson Stephen P.

EVP, General Counsel

Officer
57,745 -11.5%
5.60
US$323,372 		57,745 -11.5% 5.60 US$323,372
2024-03-07 2024-03-06 S Sale
Donley Matthew Maxwell

EVP, Ops & Strategy

Officer
40,665 -6.5%
5.51
US$224,064 		40,665 -6.5% 5.51 US$224,064
2024-02-29 2024-02-27 S Sale
Knappertz Volker

EVP, Research and Development

Officer
4,930 -1.5%
6.10
US$30,073 		4,930 -1.5% 6.10 US$30,073
2024-02-29 2024-02-27 PlS Planned sale
Knappertz, Volker

Senior Officer of Issuer

Officer
4,930 -16.0%
6.10
US$30,073 		4,930 -16.0% 6.10 US$30,073
2024-02-26 2024-02-20 PP Planned purchase
Donley, Matthew

Senior Officer of Issuer

Officer
4,930 +7.9%
4,930.00
CA$24,304,900 		4,930 +7.9% 4,930.00 CA$24,304,900
2024-02-22 2024-02-20 S Sale
Habig Scott Michael

Chief Commercial Officer

Officer
15,867 -3.1%
5.48
US$86,951 		15,867 -3.1% 5.48 US$86,951
2024-02-22 2024-02-20 S Sale
Knappertz Volker

EVP, Research and Development

Officer
25,146 -7.2%
5.48
US$137,800 		25,146 -7.2% 5.48 US$137,800
Explore more

More insider trading research around Aurinia Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America